CSL · 3 days ago
Executive Director, Regional External Innovation Lead
Americas, US-MA, Waltham, CSL Behring
Full-time
Hybrid
Director/Executive
15+ years expCSL Behring is a global biotherapeutics leader committed to saving lives through innovative therapies. The Executive Director will lead Due Diligence and Regional Ecosystem Engagement, shaping strategies to accelerate external innovation and optimizing processes across therapeutic areas.
BiotechnologyHealth CareHealth DiagnosticsMedical
Responsibilities
Design and implement an optimized DD process emphasizing consistency, speed, and efficiency across all therapeutic areas
Track progress and performance metrics to ensure effective use of TA and functional resources, driving accountability and transparency
Identify, assess, and deploy AI-based tools and best practices to enhance DD capabilities, partnering externally to bring cutting-edge solutions into CSL
Lead a team of Regional Ecosystem Leads embedded in key innovation hubs to represent CSL and source innovation aligned with TA strategies
Maintain strong local relationships and amplify CSL’s priorities at universities, incubators, accelerators, VCs, and local organizations
Partner closely with Search TA Leads to conduct regional searches, plan engagements/conferences, and share regional insights
Organize and represent CSL at local innovation events (e.g., CSL Boston Innovation Day) to strengthen visibility and partnerships
Support research-related goals through regional engagement including identifying early targets/assets and facilitating collaborations (e.g. the RAI process)
Work closely with Search TA Leads and BD teams as part of deal teams through negotiation and deal close, ensuring seamless handoff and execution
Contribute to early partnering strategies and onboarding approaches that create competitive advantage for CSL
Qualification
Required
15+ years in biopharma with significant experience in business development, external innovation, and due diligence leadership
Advanced degree required (PhD, MD, or equivalent)
Proven track record of designing and implementing scalable processes for asset evaluation and deal execution
Strong understanding of AI-enabled tools and digital solutions for DD and portfolio analytics
Deep network within biotech, academia, and innovation ecosystems globally
Preferred
Primary preferred locations for this role are King of Prussia (KoP), Waltham & Zurich
Secondary preferred locations include Melbourne and the Maidenhead
Benefits
How CSL Supports Your Well-being | CSL
Company
CSL
CSL develops innovative biotherapies and influenza vaccines that save lives, and help people with life-threatening medical conditions.
10001+ employees
Funding
Current Stage
Public CompanyTotal Funding
$111M2013-12-20Acquired
2004-02-06Post Ipo Equity· $111M
1994-06-03IPO
Leadership Team
Jeffrey Ball
Chief Sustainability Officer
Joy Linton
Strategic Advisor
Recent News
Pharma Letter
2026-01-03
2025-10-29
Company data provided by crunchbase